Stem cell hype risks "backlash"

Silversides, Ann
November 2009
CMAJ: Canadian Medical Association Journal;11/24/2009, Vol. 181 Issue 11, pE246
Academic Journal
The article informs that the stem cell research is touted as the next big thing that will kickstart economic growth. However, according to law professor Timothy Caulfield, the rising expectations could lead to a backlash. He further added that stem cell research should be subjected to good independent governance. He stated that Qatar is investing billions in stem cell research because they believe it will replace oil and bring economic boom in the future.


Related Articles

  • The origins of human embryonic stem cell research policies in the US states. Levine, Aaron D.; Lacy, T. Austin; Hearn, James C. // Science & Public Policy (SPP);Aug2013, Vol. 40 Issue 4, p544 

    Stem cell research has emerged as a state-level science and technology policy issue in recent years in the USA, with some states supporting research in the field and others choosing to restrict it. In this paper, we systematically explore the factors that are associated with US states’...

  • Q&A: Goop debunked.  // Quill & Quire;Jan/Feb2015, Vol. 81 Issue 1, p31 

    The article presents an interview with writer Timothy Caulfield in which he discusses actress Gwyneth Paltrow, celebrity diets, and celebrity culture.

  • Different Stem Cells Unhappy in Their Own Way. Breindl, Anette // BioWorld Today;1/10/2011, Vol. 22 Issue 6, Special section p2 

    The article reports on a study by scientists from the University of California, San Diego and the Scripps Research Institute published in the January 6, 2011 issue of "Cell Stem Cell," which found that human embryonic stem cells and induced pluripotent stem cells have genomic instabilities.

  • Stem Cell Efficiency: It's All Relative. Breindl, Anette // BioWorld Today;12/5/2011, Vol. 22 Issue 234, Special section p1 

    The article reports on the result of a study on the role of induced pluripotent stem cells (iPS) in mice development, which was conducted by scientists from the Whitehead Institute for Biomedical Research and published in the December 2, 2011 issue of "Cell Stem Cell."

  • KEEP TRYING.  // Commonweal;2/26/2010, Vol. 137 Issue 4, p6 

    The article focuses on the results of a long-term research which raised doubts about the theorized parity between induced pluripotent stem cells (iPS) and human embryonic stem cells (hES).

  • Italy's stem-cell challenge gaining momentum. Cattaneo, Elena; Cerbai, Elisabetta; Garagna, Silvia // Nature;2/11/2010, Vol. 463 Issue 7282, p729 

    In this article the author offers insight over the case concerning the decision of Italy to exclude the human embryonic stem cells from a ministerial research funding.

  • Panel OKs Money for Stem Cell Clinical Trials. Chambers, Heather // San Diego Business Journal;3/15/2010, Vol. 31 Issue 11, p8 

    The article reports that the governing board for the state's three billion dollars stem cell institute approved the funding for the development of new stem cell therapies in San Diego, California.

  • Stem-Cell Research – Signposts and Roadblocks.  // New England Journal of Medicine;12/22/2005, Vol. 353 Issue 25, p2728 

    A correction to the article "Stem-Cell Research-Signposts and Roadblocks," that was published in the July 7, 2005 issue is presented.

  • Editorial. Williams, Clare // Clinical Ethics;2006, Vol. 1 Issue 4, p209 

    The article discusses various reports published within the issue, including one by Helen Busby on how individuals reflected on consent for epidemiology, and another by Naomi Pfeffer and Julie Kent on their stem cell initiative project.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics